vTv Therapeutics (VTVT) Equity Ratio (2016 - 2025)
Historic Equity Ratio for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to 0.71.
- vTv Therapeutics' Equity Ratio rose 7084.82% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 7084.82%. This contributed to the annual value of 0.37 for FY2024, which is 11668.44% up from last year.
- As of Q3 2025, vTv Therapeutics' Equity Ratio stood at 0.71, which was up 7084.82% from 0.1 recorded in Q2 2025.
- vTv Therapeutics' 5-year Equity Ratio high stood at 0.71 for Q3 2025, and its period low was 3.36 during Q1 2021.
- In the last 5 years, vTv Therapeutics' Equity Ratio had a median value of 0.38 in 2021 and averaged 0.58.
- In the last 5 years, vTv Therapeutics' Equity Ratio tumbled by 59322.3% in 2023 and then skyrocketed by 17204.23% in 2024.
- vTv Therapeutics' Equity Ratio (Quarter) stood at 0.38 in 2021, then rose by 15.49% to 0.32 in 2022, then crashed by 593.22% to 2.24 in 2023, then skyrocketed by 116.68% to 0.37 in 2024, then soared by 89.72% to 0.71 in 2025.
- Its last three reported values are 0.71 in Q3 2025, 0.1 for Q2 2025, and 0.28 during Q1 2025.